C4 Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Okay. Good morning, and welcome again to the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst for the firm. Our next presenting company is C4 Therapeutics, and to talk to us a little bit about the company, it's my pleasure to introduce CEO, Andrew Hirsch. There will be a Q&A session after the presentation. Feel free to submit questions by clicking the Ask A Question icon.
With that, Andrew, thanks so much for sharing some of your time with us this morning.
Great. Thanks, Eric. Good morning, everyone, and thanks for joining our presentation. Before I begin, I'd like to thank JPMorgan for inviting us to participate in the conference, and I'm pleased to share an update on C4 Therapeutics today.
You should all have access to the slides, that I'll indicate which slide number I'm on as I progress through the presentation. I'll be making forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |